Canada Pension Plan Investment Board Grows Stock Holdings in Teladoc Health, Inc. $TDOC

Key Points

• The Canada Pension Plan Investment Board increased its holdings in Teladoc Health by 40.7% in Q1, owning 321,800 shares worth approximately $2.56 million.
• Analysts have lowered price targets for Teladoc Health, with Wells Fargo setting it at $8.00 and Bank of America at $7.00, while the average target is currently $9.80.
• Teladoc Health reported a quarterly earnings of ($0.19) EPS, surpassing expectations, despite a 1.6% year-over-year decline in revenue at $631.90 million.

Canada Pension Plan Investment Board lifted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 40.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 321,800 shares of the health services provider's stock after purchasing an additional 93,100 shares during the period. Canada Pension Plan Investment Board owned approximately 0.18% of Teladoc Health worth $2,562,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Cambridge Investment Research Advisors Inc. raised its position in Teladoc Health by 60.8% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock valued at $316,000 after buying an additional 15,030 shares during the period. Golden State Wealth Management LLC raised its holdings in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after acquiring an additional 1,690 shares in the last quarter. Wedmont Private Capital raised its stake in Teladoc Health by 20.3% during the first quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock worth $117,000 after acquiring an additional 2,715 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Teladoc Health by 22.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock valued at $134,000 after purchasing an additional 2,662 shares during the last quarter. Finally, American Century Companies Inc. raised its position in Teladoc Health by 78.8% in the 1st quarter. American Century Companies Inc. now owns 375,050 shares of the health services provider's stock valued at $2,985,000 after purchasing an additional 165,332 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

TDOC has been the topic of several research reports. Mizuho initiated coverage on Teladoc Health in a research note on Friday, July 25th. They set a "neutral" rating and a $10.00 price target on the stock. Bank of America decreased their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday, May 28th. Evercore ISI upped their price objective on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Finally, Truist Financial dropped their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a report on Tuesday, May 27th. Six research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and a consensus price target of $9.80.

Teladoc Health Trading Down 1.2%

TDOC traded down $0.10 during midday trading on Tuesday, hitting $7.75. 1,307,103 shares of the company were exchanged, compared to its average volume of 6,780,760. The firm's 50 day moving average price is $7.76 and its 200-day moving average price is $7.76. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $1.37 billion, a P/E ratio of -6.52 and a beta of 1.84.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm had revenue of $631.90 million during the quarter, compared to analyst estimates of $621.91 million. During the same period in the previous year, the company posted ($0.38) EPS. The company's revenue for the quarter was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, equities analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.